In the second installment of our two-part focus on the re-emergence of endoAVF systems during CX 2026, host Nick Inston (University Hospital Birmingham NHS Foundation Trust, Birmingham, UK) and guests Alexandros Mallios (Hôpital Paris Saint-Joseph, Paris, France), Kate Steiner (University Hospitals Sussex NHS Foundation Trust, Brighton, UK) and Bart Dolmatch (Palo Alto Medical Foundation, Palo Alto, USA) discuss second-generation devices, the data behind first-generation technology, and the prospect of third-generation contenders.
Watch the first installment—The death and re-birth of endoAVF systems, part one: “The only thing that stifled it was withdrawal from the market”—here.
